HPCM
TECH icon

Hunter Perkins Capital Management’s Bio-Techne TECH Stock Holding History

Hunter Perkins Capital Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-20,000
Closed -$1.11M – 121
2025
Q3 		$1.11M Hold
20,000
– – 0.25% 75
2025
Q2 		$1.03M Buy
+20,000
New +$1M 0.24% 72

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Hunter Perkins Capital Management's TECH Position: Q4 2025 in Review

Hunter Perkins Capital Management sold out of Bio-Techne (TECH) in Q4 2025, closing a stake of 20,000 shares — an estimated $1.11M sold.

Hunter Perkins Capital Management first reported a position in TECH in Q2 2025 and held it in 2 quarters. The position peaked at $1.11M in Q3 2025. 585 funds tracked by Wall St. Rank hold TECH as of Q4 2025.

  • Hunter Perkins Capital Management reported no remaining Bio-Techne position as of Q4 2025 after selling out during the quarter.
  • Hunter Perkins Capital Management sold 20,000 Bio-Techne shares in Q4 2025, an estimated $1.11M.
  • Hunter Perkins Capital Management first reported a position in Bio-Techne in Q2 2025 and held it in 2 quarters.
  • Hunter Perkins Capital Management's Bio-Techne position peaked at $1.11M in Q3 2025.
  • 585 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2025.

Based on Hunter Perkins Capital Management's 13F filing for Q4 2025, filed 14 Jan 2026.